<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Approach to the child with tachycardia</title><link href="/z/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/z/d/css/icofont.min.css" rel="stylesheet"/><link href="/z/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/z/d/css/animate.css" rel="stylesheet"/><link href="/z/d/css/owl.carousel.css" rel="stylesheet"/><link href="/z/d/css/magnific-popup.css" rel="stylesheet"/><link href="/z/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/z/d/css/style.css" rel="stylesheet"/><link href="/z/d/css/rtl_edited.css" rel="stylesheet"/><link href="/z/d/css/responsive.css" rel="stylesheet"/><link href="https:///uptodate_assets/main.css" rel="stylesheet"/>
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>
<meta content="" name="description"/>
<link href="/z/d/img/favicon.png" rel="icon" type="image/png">
</link></head>
<body>
<!-- Start Main Menu Area -->
<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>
<section class="teacher-area ptb-10">
<div class="container">
</div>
<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Approach to the child with tachycardia</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="topicTitle">Approach to the child with tachycardia</div> <div class="authorSectionElem"><div class="authorsElementsLeft"><dl id="topicContributors"><dt><span> </span>Authors:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Suzan Mazor, MD</a></dd><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Robert Mazor, MD</a></dd><dt><span> </span>Section Editors:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">George A Woodward, MD</a></dd><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Sanghamitra M Misra, MD, MEd</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">James F Wiley, II, MD, MPH</a></dd></dl></div><div class="authorsElementsRight"><div id="literatureReviewDate"><div class="litReviewSingleLine"><bdi><span class="emphasis">Literature review current through:</span> Jan 2024.</bdi></div><div class="litReviewSingleLine"><bdi><span class="emphasis">This topic last updated:</span> Nov 08, 2022.</bdi></div></div></div></div><div id="topicWhatsNewContainer"></div><div id="topicText"><p class="headingAnchor" id="H1"><span class="h1">INTRODUCTION</span><span class="headingEndMark"> — </span>Tachycardia is common in the pediatric age group, and the etiology is often benign. A parent/caregiver or other observer may describe tachycardia based on observation of the child's neck veins, palpation of the pulse, or sensation of the heart beating rapidly while holding the child. All complaints of tachycardia require rapid assessment of patient status and cardiac rhythm. In most instances, life-threatening tachycardia can be rapidly detected and treated. This topic will review the differential diagnosis and approach to the child who presents with tachycardia.</p><p class="headingAnchor" id="H2"><span class="h1">DIFFERENTIAL DIAGNOSIS</span><span class="headingEndMark"> — </span>The differential diagnosis of tachycardia in children is provided in the table  (<a class="graphic graphic_table graphicRef71622" href="/z/d/graphic/71622.html" rel="external">table 1</a>).</p><p class="headingAnchor" id="H3"><span class="h2">Life-threatening cardiac conditions</span><span class="headingEndMark"> — </span>Most life-threatening cardiac conditions in children that present as tachycardia consist of supraventricular tachycardias. However, any type of arrhythmia may occur depending on specific patient predisposition [<a href="#rid1">1</a>].</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Supraventricular tachycardia (SVT)</strong> – While the term "SVT" technically includes the entire group of tachycardias whose mechanisms involve the atria and/or atrioventricular (AV) node, in common parlance the term also describes the most common pathologic supraventricular tachycardia in children: tachycardia caused by an accessory AV pathway (eg, AV reentrant tachycardia). The dual use of this term can lead to confusion when communicating among team members and consultants.</p><p></p><p class="bulletIndent1">SVT may present with palpitations, chest pain, or shortness of breath in children, or with lethargy, feeding difficulties, or irritability in infants. In many instances, a parent/caregiver or health care provider notes a rapid heart rate during routine care. In newborns and infants with SVT, the heart rate is typically &gt;220 beats per minute (BPM), while in older children the heart rate is &gt;180 BPM [<a href="#rid2">2</a>].</p><p></p><p class="bulletIndent1">Children may exhibit a range of clinical findings, from no symptoms to cardiogenic shock, depending on the duration of SVT.</p><p></p><p class="bulletIndent1">The term Wolff-Parkinson-White syndrome (WPW) is applied when there is a shortened PR interval and ventricular pre-excitation on the resting electrocardiogram (ECG) due to the accessory pathway. If the accessory pathway is not apparent on resting ECG, the pathway is considered "concealed". SVT may also be associated with drug exposure, especially sympathomimetics contained in high caffeine drinks, cough/cold medications, short-acting beta agonists, and dietary supplements, or congenital heart disease (eg, Ebstein anomaly, repaired dextrotransposition of the great arteries, single ventricle lesions after Fontan operation). (See  <a class="medical medical_review" href="/z/d/html/6496.html" rel="external">"Approach to the child with occult toxic exposure"</a> and  <a class="medical medical_review" href="/z/d/html/5783.html" rel="external">"Clinical features and diagnosis of supraventricular tachycardia (SVT) in children"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Ventricular tachycardia (VT)</strong> – This arrhythmia is uncommon in the pediatric population. VT may result from electrolyte abnormalities (hyperkalemia, hypocalcemia, and hypomagnesemia), congenital heart disorders, myocarditis, myocardial ischemia caused by congenital abnormality of the coronary arteries, or drug toxicity. In addition, patients who have undergone cardiac surgery (eg, ventriculotomy for repair of tetralogy of Fallot) are at risk for these dysrhythmias due to postoperative ventricular scarring [<a href="#rid3">3</a>]. (See  <a class="medical medical_review" href="/z/d/html/5786.html" rel="external">"Causes of wide QRS complex tachycardia in children"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Torsades de Pointes (TdP) </strong>– TdP, or polymorphous ventricular tachycardia, is the hallmark dysrhythmia associated with long QT syndrome (LQTS). LQTS may be hereditary (Jervell-Lange-Nielsen syndrome or Romano-Ward syndrome) or acquired [<a href="#rid4">4</a>]. Acquired TdP may follow hypokalemia, hypocalcemia, hypomagnesemia, and ingestion of drugs with sodium channel or inwardly rectifying potassium channel blocking properties, such as cyclic antidepressants and certain antiarrhythmic medications  (<a class="graphic graphic_table graphicRef66773" href="/z/d/graphic/66773.html" rel="external">table 2</a>). TdP has the potential to rapidly deteriorate into ventricular fibrillation and sudden death [<a href="#rid5">5</a>]. (See  <a class="medical medical_review" href="/z/d/html/1036.html" rel="external">"Congenital long QT syndrome: Epidemiology and clinical manifestations"</a> and  <a class="medical medical_review" href="/z/d/html/1043.html" rel="external">"Acquired long QT syndrome: Definitions, pathophysiology, and causes"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Atrial flutter</strong> – Atrial flutter is a supraventricular tachycardia that is caused by an intraatrial reentry circuit. Most children with atrial flutter have an underlying heart abnormality, such as repaired or palliated congenital heart disease. Though most patients with atrial flutter are hemodynamically stable, there is a risk of sudden death if this dysrhythmia cannot be medically or surgically controlled [<a href="#rid6">6</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Hypertrophic cardiomyopathy (HCM)</strong> – HCM manifests as a hypertrophied, nondilated left ventricle and septum. Patients with HCM may present with palpitations, syncope, or cardiac arrest during strenuous exercise. Tachycardias in these patients can be either supraventricular, including sinus tachycardia, or ventricular. The subset of HCM patients who present with syncope are at significant risk for sudden death [<a href="#rid7">7</a>]. (See  <a class="medical medical_review" href="/z/d/html/4951.html" rel="external">"Hypertrophic cardiomyopathy in children: Clinical manifestations and diagnosis"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Myocarditis</strong> – This inflammation of the myocardium is most commonly viral in origin, with Coxsackie virus B and other enteroviruses accounting for most cases. Clinical findings of myocarditis include tachycardia, typically sinus or ventricular, out of proportion to fever or at rest, poor perfusion, and signs of heart failure. Patients with myocarditis may progress rapidly to cardiogenic shock [<a href="#rid8">8</a>]. (See  <a class="medical medical_review" href="/z/d/html/5755.html" rel="external">"Clinical manifestations and diagnosis of myocarditis in children"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Pericardial effusion with cardiac tamponade</strong> – This condition may occur in patients with infectious pericarditis, blunt chest trauma, or as a component of post-pericardiotomy syndrome in patients with fever and large pericardial effusion following recent heart surgery. Sinus tachycardia is seen in almost all patients, allowing for at least partial maintenance of cardiac output. (See  <a class="medical medical_review" href="/z/d/html/4941.html" rel="external">"Pericardial effusion: Approach to diagnosis"</a>.)</p><p></p><p class="headingAnchor" id="H4"><span class="h2">Life-threatening noncardiac conditions</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Substrate deficiency</strong> – Oxygen and glucose are key physiologic substrates. Both hypoxemia and hypoglycemia are important causes of sinus tachycardia and are life-threatening if not immediately recognized and treated.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Hypovolemic shock</strong> – Inadequate perfusion of tissues caused by hemorrhage or extravascular fluid loss results in sinus tachycardia with vasoconstriction and a narrowed pulse pressure. (See  <a class="medical medical_review" href="/z/d/html/6389.html" rel="external">"Hypovolemic shock in children in resource-abundant settings: Initial evaluation and management"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Electrolyte imbalance</strong> – Hyperkalemia and hypocalcemia are caused by a variety of conditions and are associated with atrial and ventricular tachyarrhythmias. (See  <a class="medical medical_review" href="/z/d/html/2377.html" rel="external">"Causes and evaluation of hyperkalemia in adults"</a> and  <a class="medical medical_review" href="/z/d/html/837.html" rel="external">"Diagnostic approach to hypocalcemia"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Sepsis </strong>– Sinus tachycardia may be an early and persistent sign of obvious or occult sepsis and accompanies septic shock. (See  <a class="medical medical_review" href="/z/d/html/6395.html" rel="external">"Sepsis in children: Definitions, epidemiology, clinical manifestations, and diagnosis"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Anaphylaxis</strong> – Anaphylaxis is usually characterized by a defined exposure to a potential trigger, followed by rapid onset, evolution, and resolution of cutaneous, respiratory, cardiovascular, and/or gastrointestinal symptoms within minutes to hours. (See  <a class="medical medical_review" href="/z/d/html/392.html" rel="external">"Anaphylaxis: Emergency treatment"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Toxic exposure</strong> – Many toxic exposures have the potential to cause life-threatening tachyarrhythmias. The specific arrhythmia depends on the characteristics of the toxic agent  (<a class="graphic graphic_table graphicRef66773" href="/z/d/graphic/66773.html" rel="external">table 2</a>).</p><p></p><p class="headingAnchor" id="H5"><span class="h2">Common conditions</span><span class="headingEndMark"> — </span>Sinus tachycardia may result from exercise, fever, anemia, drugs (especially caffeine), anxiety/hyperventilation syndrome, emotional arousal, and pain  (<a class="graphic graphic_table graphicRef71622" href="/z/d/graphic/71622.html" rel="external">table 1</a>).</p><p class="headingAnchor" id="H6"><span class="h2">Other conditions</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Acute rheumatic fever</strong> – Acute rheumatic fever (ARF) is a delayed, nonsuppurative sequela of a pharyngeal infection with the group A streptococcus. Fever and pancarditis are clinical manifestations of this disease that can rarely cause tachydysrhythmias [<a href="#rid9">9</a>]. Other findings include arthralgia, arthritis, erythema marginatum, subcutaneous nodules, and chorea. Testing for recent streptococcal infection is essential to establish the diagnosis. (See  <a class="medical medical_review" href="/z/d/html/3177.html" rel="external">"Acute rheumatic fever: Clinical manifestations and diagnosis"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Hyperthyroidism</strong> – Patients with hyperthyroidism have an increase in cardiac output, caused by both increased peripheral oxygen needs and increased cardiac contractility. Heart rate is increased, pulse pressure is widened, and peripheral vascular resistance is decreased [<a href="#rid10">10</a>]. Atrial fibrillation, which occurs in 10 to 20 percent of adults with hyperthyroidism, is rare in children. Mitral valve prolapse is two to three times more prevalent in hyperthyroid patients than in normal subjects [<a href="#rid11">11</a>]. (See  <a class="medical medical_review" href="/z/d/html/5841.html" rel="external">"Clinical manifestations and diagnosis of Graves disease in children and adolescents"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Kawasaki disease</strong> – Kawasaki disease is a systemic inflammation that typically presents with fever and irritability. Other diagnostic criteria include bilateral nonexudative conjunctivitis, erythema of the lips and oral mucosa, rash, extremity changes, and lymphadenopathy. Tachycardia accompanies fever and may also signify serious cardiac effects such as pericardial effusion, heart failure, and coronary artery aneurysm. (See  <a class="medical medical_review" href="/z/d/html/6417.html" rel="external">"Kawasaki disease: Clinical features and diagnosis"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Pheochromocytoma</strong> – Pheochromocytomas and paragangliomas are rare neoplasms in children. Tumors that arise from the adrenal medulla are termed pheochromocytomas, and those with extraadrenal origins are called paragangliomas. The classic triad of symptoms in these disorders consists of episodic headache, sweating, and tachycardia, usually accompanied by hypertension. Malignant hypertension can occur, with its associated complications (eg, increased intracranial pressure, encephalopathy). (See  <a class="medical medical_review" href="/z/d/html/5850.html" rel="external">"Pheochromocytoma and paraganglioma in children"</a> and  <a class="medical medical_review" href="/z/d/html/3833.html" rel="external">"Moderate to severe hypertensive retinopathy and hypertensive encephalopathy in adults"</a>.)</p><p></p><p class="headingAnchor" id="H4098188374"><span class="h1">EVALUATION</span></p><p class="headingAnchor" id="H7"><span class="h2">History</span><span class="headingEndMark"> — </span>A thorough history can help the clinician delineate the cause of tachycardia.</p><p class="bulletIndent1"><span class="glyph">●</span>Feeding difficulty with tachypnea – Infants with heart failure may present with a history of sweating with feeds, feeding difficulty and tachypnea, or agitation.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Precipitating factors – Fever, anemia, and exercise are common causes of sinus tachycardia.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Emotional state – The patient's emotional state before the onset of tachycardia should be discussed to determine the likelihood of anxiety as the cause of symptoms.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Recent medications, intoxication, drug, and caffeine use – Sympathomimetic medications may be a trigger for tachycardia and/or arrhythmias, such as cough or cold preparations (see  <a class="medical medical_review" href="/z/d/html/16258.html" rel="external">"Over-the-counter cough and cold preparations: Approach to pediatric poisoning", section on 'Phenylephrine and similar decongestants'</a>), beta-agonists, toxic exposures, drugs of abuse, unregulated dietary substances such as ephedra, caffeine-containing beverages, and weight-loss supplements  (<a class="graphic graphic_table graphicRef66773" href="/z/d/graphic/66773.html" rel="external">table 2</a>). (See  <a class="medical medical_review" href="/z/d/html/6496.html" rel="external">"Approach to the child with occult toxic exposure"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Illness/fever – A history of viral illness or fever in conjunction with respiratory distress or myocardial dysfunction suggests myocarditis, especially if tachycardia is out of proportion to the degree of fever or is present after defervescence. (See  <a class="medical medical_review" href="/z/d/html/5755.html" rel="external">"Clinical manifestations and diagnosis of myocarditis in children"</a>.)</p><p></p><p class="bulletIndent1">A history of a recent streptococcal infection in the febrile patient with tachycardia raises clinical suspicion for acute rheumatic fever. If signs of carditis, such as a murmur of mitral valve regurgitation or pericardial rub are present, then the patient meets Jones criteria for the diagnosis of acute rheumatic fever. (See  <a class="medical medical_review" href="/z/d/html/3177.html" rel="external">"Acute rheumatic fever: Clinical manifestations and diagnosis"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Heart disease/heart surgery – A history of heart disease or heart surgery increases the risk of secondary atrial and ventricular tachyarrhythmias and post-pericardiotomy syndrome.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Family history – Family history of sudden cardiac death or deafness may raise clinical suspicion for genetic disorders such as long QT syndrome and hypertrophic cardiomyopathy that may cause sudden onset of ventricular tachycardia.</p><p></p><p class="headingAnchor" id="H8"><span class="h2">Physical examination</span><span class="headingEndMark"> — </span>The patient's hemodynamic status drives decision making for the tachycardic patient. Therefore, the initial general assessment of hemodynamic stability is of paramount importance when evaluating a patient with tachycardia. Clinicians should emergently treat the patient with cardiovascular collapse per American Heart Association guidelines for cardiopulmonary resuscitation  (<a class="graphic graphic_algorithm graphicRef129940" href="/z/d/graphic/129940.html" rel="external">algorithm 1</a>) [<a href="#rid2">2</a>].</p><p class="headingAnchor" id="H9"><span class="h3">Vital signs</span><span class="headingEndMark"> — </span>Tachycardia is defined as the presence of a heart rate value greater than expected for age. Although values are published for specific age groups  (<a class="graphic graphic_table graphicRef78097" href="/z/d/graphic/78097.html" rel="external">table 3</a>), clinicians may use the basic guideline of &gt;160 BPM for infants (&lt;2 years), &gt;140 BPM for children (2 to 12 years), and &gt;100 BPM for adolescents and adults to define tachycardia  (<a class="graphic graphic_table graphicRef77057" href="/z/d/graphic/77057.html" rel="external">table 4</a>). Oxygen desaturation may be present in patients with unrepaired or palliated congenital heart disease.</p><p>Fever suggests the presence of infection and is most commonly associated with sinus tachycardia although the stress of infection may also precipitate many dysrhythmias.</p><p>In febrile children with sinus tachycardia, the heart rate increase attributable to elevated temperature may be adjusted by deducting approximately 10 beats/minute for every 1°C elevation in temperatures above 37°C [<a href="#rid12">12-14</a>]. This correction may be of diagnostic benefit when determining the etiology of tachycardia. However, if fever is felt to be the cause of tachycardia, then the elevated heart rate should resolve when the temperature returns to normal.</p><p class="headingAnchor" id="H10"><span class="h3">Cardiovascular findings</span><span class="headingEndMark"> — </span>Rate irregularity, if present, should be noted. Distant-sounding heart tones may be present in pericardial effusion with tamponade along with pulsus paradoxus. Third and fourth heart sounds or gallop rhythm suggest the presence of myocardial dysfunction. The presence of a murmur suggests underlying structural heart disease. However, innocent "flow" murmurs may be accentuated by hyperdynamic states such as fever, anemia, and sepsis. A laterally displaced point of maximum Impulse (PMI) suggests the presence of cardiomegaly. (See  <a class="medical medical_review" href="/z/d/html/4936.html" rel="external">"Pulsus paradoxus in pericardial disease"</a> and  <a class="medical medical_review" href="/z/d/html/5766.html" rel="external">"Irregular heart rhythm (arrhythmias) in children"</a> and  <a class="medical medical_review" href="/z/d/html/103723.html" rel="external">"Approach to the infant or child with a cardiac murmur"</a>.)</p><p class="headingAnchor" id="H11"><span class="h3">Non-cardiovascular findings</span><span class="headingEndMark"> — </span>Dry-appearing or "tacky" mucous membranes suggest dehydration/hypovolemia. Pallor is seen with anemia. Tachypnea, rales, and hepatomegaly are signs of heart failure. Poor perfusion with bounding pulses suggests the "warm shock" of sepsis. Headache and diaphoresis are associated with pheochromocytoma. A widened pulse pressure and thyromegaly may indicate hyperthyroidism.</p><p class="headingAnchor" id="H12"><span class="h2">Ancillary studies</span><span class="headingEndMark"> — </span>In the acutely symptomatic patient with tachycardia, monitoring and assessment of the cardiac rhythm and blood pressure is vital. Bedside cardiac monitors often do not provide satisfactory rhythm tracings to permit detailed decision making. Thus, a standard 12-lead ECG and rhythm strip should be obtained upon presentation and concurrent with any attempts at cardioversion or defibrillation to guide therapy and provide valuable data should the patient require pediatric cardiology consultation [<a href="#rid15">15</a>]. Even in the asymptomatic patient, continuous monitoring and a standard ECG is often helpful since an ECG is essential in the diagnosis of WPW and long QT syndrome and may be helpful in the diagnosis of premature atrial and ventricular complexes.</p><p>Clinicians should evaluate the presence of electrolyte abnormalities by performing rapid determinations of serum electrolytes, glucose, and calcium. Readily available hemoglobin/hematocrit point of care testing can confirm clinical suspicion of anemia.</p><p>Patients with sepsis warrant measurement of a complete blood count with differential and detection of the causative organism through appropriate cultures of the blood, urine, and cerebrospinal fluid. In addition, wound cultures and nasopharyngeal swabs for <em>Staphylococcus aureus</em> are important adjuncts for detection of toxic shock and toxic streptococcal syndromes. (See  <a class="medical medical_review" href="/z/d/html/6467.html" rel="external">"Approach to the ill-appearing infant (younger than 90 days of age)"</a>.)</p><p>Clinical findings suggestive of hyperthyroidism can be confirmed by serum thyroid testing. Serum levels of thyroxine (T4) and triiodothyronine (T3) are elevated, and TSH secretion is suppressed in hyperthyroidism. (See  <a class="medical medical_review" href="/z/d/html/5841.html" rel="external">"Clinical manifestations and diagnosis of Graves disease in children and adolescents"</a>.)</p><p>If the patient presents with an acute tachydysrhythmia, the clinician should obtain an echocardiogram to evaluate myocardial function, as well as to evaluate for underlying structural heart disease soon after normal sinus rhythm is established. In the hemodynamically unstable patient, this study should be performed on an emergent basis, as the information will affect therapeutic decision making. Given its availability in most clinical settings, it is reasonable to get a screening chest radiograph to look for cardiomegaly as supportive data to proceed with cardiology consultation and echocardiogram. (See  <a class="medical medical_review" href="/z/d/html/5765.html" rel="external">"Suspected heart disease in infants and children: Criteria for referral", section on 'Timing of referral'</a>.)</p><p>Cardiac troponin levels (troponin-I and -T) may be elevated in myocarditis. However, myocardial enzymes (creatine kinase [CK], MB isoenzyme of CK [CK-MB]) levels are generally not helpful as they are rarely abnormal [<a href="#rid8">8</a>]. Serum PCR identification of a viral infection, or viral isolation from other body sites, such as the oropharynx or gastrointestinal tract, can support the diagnosis.</p><p>Antistreptolysin O (ASO), anti-deoxyribonuclease B (anti-DNase B), and antihyaluronidase titers are essential for documenting antecedent streptococcal infection as part of the diagnosis of rheumatic fever [<a href="#rid16">16</a>].</p><p class="headingAnchor" id="H13"><span class="h1">ALGORITHMIC APPROACH</span><span class="headingEndMark"> — </span>The majority of previously healthy pediatrics patients presenting with tachycardia have a febrile illness, mild to moderate dehydration, or anxiety. Ascertainment of a history of known cardiac disease, assessment for shock, and the determination of rhythm are three key decision points in the evaluation of children with tachycardia  (<a class="graphic graphic_algorithm graphicRef51655" href="/z/d/graphic/51655.html" rel="external">algorithm 2</a>). Cardiac arrhythmias, other than sinus tachycardia, are rare in children. A past medical history of congenital heart disease, cardiac surgery, or a family history of sudden death significantly increases the likelihood of life-threatening atrial and ventricular arrhythmias.</p><p class="headingAnchor" id="H14"><span class="h2">Shock</span><span class="headingEndMark"> — </span>The child with tachycardia and shock should be triaged and managed per the American Heart Association (AHA) guidelines for assessment of cardiopulmonary instability espoused in the Pediatric Advanced Life Support (PALS) course [<a href="#rid2">2</a>]. A key component of this assessment requires categorization of the QRS complex from the cardiorespiratory (CR) monitor or 12-lead ECG as narrow or wide  (<a class="graphic graphic_algorithm graphicRef129940" href="/z/d/graphic/129940.html" rel="external">algorithm 1</a>) [<a href="#rid2">2,17</a>]. A 12-lead ECG before, during, and after intervention is preferable if patient status allows.</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Wide complex tachycardia</strong> – Hemodynamically unstable patients with wide complex tachycardia most commonly have VT or SVT with aberrancy (eg, a rate-related bundle branch block where differential properties for impulse conduction between the bundles of His lead to a wide QRS complex despite a supraventricular mechanism). Although there are exceptions, a patient with wide QRS complex tachycardia should be considered to have ventricular tachycardia until an alternative diagnosis can be confirmed. Hyperkalemia, hypocalcemia, hypomagnesemia, or toxic exposures are important etiologies of unstable VT that require specific therapy beyond AHA guidelines for successful rhythm termination  (<a class="graphic graphic_algorithm graphicRef129940" href="/z/d/graphic/129940.html" rel="external">algorithm 1</a>). Type 1a and 1c antiarrhythmic agents (eg, <a class="drug drug_pediatric" data-topicid="12732" href="/z/d/drug information/12732.html" rel="external">procainamide</a>, <a class="drug drug_pediatric" data-topicid="13302" href="/z/d/drug information/13302.html" rel="external">flecainide</a>) are contraindicated in patients with drug induced ventricular tachycardia. (See  <a class="medical medical_review" href="/z/d/html/5758.html" rel="external">"Management and evaluation of wide QRS complex tachycardia in children"</a>.)</p><p></p><p class="bulletIndent1">Patients with Torsades de Pointes should receive intravenous <a class="drug drug_pediatric" data-topicid="12982" href="/z/d/drug information/12982.html" rel="external">magnesium sulfate</a> if initial cardioversion is unsuccessful. (See  <a class="medical medical_review" href="/z/d/html/116011.html" rel="external">"Acquired long QT syndrome: Clinical manifestations, diagnosis, and management", section on 'Patients with acute TdP'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Narrow complex tachycardia</strong> – In a child with a narrow complex arrhythmia, clinicians should classify the patient's rhythm as "sinus" or "non-sinus" by identifying the morphology and timing of the P waves.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Supraventricular tachycardia (SVT)</strong> – Approximately 90 percent of pediatric patients who have non-sinus, narrow complex tachycardia will have atrioventricular reentrant (typical) supraventricular tachycardia [<a href="#rid18">18</a>]. Other patients, especially those with underlying structural heart disease, present with other forms of SVT [<a href="#rid19">19</a>]. Rapid intravenous administration of <a class="drug drug_pediatric" data-topicid="13258" href="/z/d/drug information/13258.html" rel="external">adenosine</a> may be attempted first if intravenous access is immediately available. Otherwise, unstable patients should receive synchronized cardioversion at 0.5 to 1 J/kg  (<a class="graphic graphic_algorithm graphicRef129940" href="/z/d/graphic/129940.html" rel="external">algorithm 1</a>). Adenosine should be used with extreme caution in patients who have undergone heart transplantation. Denervation of the graft organ may predispose the patient to an extended period of ventricular asystole with standard dose adenosine [<a href="#rid20">20</a>]. (See  <a class="medical medical_review" href="/z/d/html/5782.html" rel="external">"Management of supraventricular tachycardia (SVT) in children"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Sinus tachycardia</strong> – Sinus tachycardia, a nonspecific sign with a wide differential diagnosis, is the most common narrow complex arrhythmia found in children with shock. Initial care must evaluate for substrate deficiency (ie, hypoxemia or hypoglycemia) that is frequently associated with shock. Although the cause of shock may not be initially apparent, treatment must begin immediately. A systematic approach to the evaluation of children with evidence of poor perfusion typically identifies features of the history, physical examination, and ancillary studies that suggest the etiology of the underlying condition  (<a class="graphic graphic_algorithm graphicRef81356" href="/z/d/graphic/81356.html" rel="external">algorithm 3</a>). (See  <a class="medical medical_review" href="/z/d/html/6396.html" rel="external">"Initial evaluation of shock in children"</a>.)</p><p></p><p class="headingAnchor" id="H15"><span class="h2">No shock</span><span class="headingEndMark"> — </span>Pediatric patients with an acute, ongoing episode of tachycardia may have signs of cardiac disease even though shock is not present  (<a class="graphic graphic_algorithm graphicRef58268" href="/z/d/graphic/58268.html" rel="external">algorithm 4</a>). Typically, there is adequate time to obtain a 12-lead ECG and rhythm strip to categorize the QRS complex as narrow or wide. In addition, a 12 lead ECG obtained prior to and during any therapeutic interventions is essential because the data will allow thorough review of the event by a pediatric cardiologist and will affect long term decision making [<a href="#rid21">21</a>].</p><p>Cardiac arrhythmias other than sinus tachycardia are rare in children. A past medical history of congenital heart disease, cardiac surgery, or a family history of sudden death significantly increases the likelihood of life-threatening atrial and ventricular arrhythmias.</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Wide complex tachycardia</strong> – In a stable patient with wide QRS complex tachycardia, the goals of the initial evaluation include the following:</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>To determine if the wide QRS complex tachycardia originates from the ventricles or is supraventricular with aberrant intraventricular conduction. The treatment and long-term prognosis differs between children with VT versus those with SVT.</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>To determine what therapeutic intervention(s) is required acutely.</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>After determining the origin of the wide QRS complex tachycardia in the stable patient, treatment can be targeted to the specific arrhythmia. (See  <a class="medical medical_review" href="/z/d/html/5758.html" rel="external">"Management and evaluation of wide QRS complex tachycardia in children"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Supraventricular tachycardia (SVT)</strong> – SVT is characterized by a nonspecific history, absent P waves, no beat-to-beat variability, and a heart rate that is ≥220 beats per minute in infants &lt;1 year of age and ≥180 beats per minute in older children. Stable patients with SVT may initially undergo vagal maneuvers to convert to sinus rhythm. First line medical therapy consists of rapid intravenous infusion of <a class="drug drug_pediatric" data-topicid="13258" href="/z/d/drug information/13258.html" rel="external">adenosine</a> (0.1 mg/kg)  (<a class="graphic graphic_algorithm graphicRef129940" href="/z/d/graphic/129940.html" rel="external">algorithm 1</a>). If the patient's rhythm cannot be readily determined because the P waves cannot be identified, it is reasonable to give a dose of adenosine while recording a rhythm strip for diagnostic purposes. If the patient does not have a reentrant mechanism, the resultant slowing of the ventricular rate caused by adenosine will often allow for more specific identification of the P wave. (See  <a class="medical medical_review" href="/z/d/html/5782.html" rel="external">"Management of supraventricular tachycardia (SVT) in children"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Ill appearance</strong> – Ill-appearing patients with sinus tachycardia should be assessed for fever and pain. Febrile children warrant careful examination for physical findings of acute rheumatic fever, Kawasaki disease, or sepsis. Severe hypertension, headache, and diaphoresis are seen following the endogenous catecholamine surge that occurs in patients with pheochromocytoma. (See  <a class="medical medical_review" href="/z/d/html/3177.html" rel="external">"Acute rheumatic fever: Clinical manifestations and diagnosis"</a> and  <a class="medical medical_review" href="/z/d/html/6417.html" rel="external">"Kawasaki disease: Clinical features and diagnosis"</a> and  <a class="medical medical_review" href="/z/d/html/5850.html" rel="external">"Pheochromocytoma and paraganglioma in children"</a>.)</p><p></p><p>Well-appearing children with sinus tachycardia usually require no studies if the tachycardia abates with resolution of the suspected underlying cause (eg, a crying child with tachycardia who has a normal rate when quiet). A history of ingestion of caffeinated beverages, diet supplements, herbal preparations, over the counter sympathomimetic or anticholinergic medications, or illicit drugs identifies drug induced sinus tachycardia  (<a class="graphic graphic_table graphicRef66773" href="/z/d/graphic/66773.html" rel="external">table 2</a>).</p><p>Patients with pallor should have complete blood and reticulocyte counts drawn to identify and characterize anemia. (See  <a class="medical medical_review" href="/z/d/html/5927.html" rel="external">"Approach to the child with anemia"</a>.)</p><p>Serum thyroid function tests are indicated in children with a goiter or other manifestations of hyperthyroidism. (See  <a class="medical medical_review" href="/z/d/html/5841.html" rel="external">"Clinical manifestations and diagnosis of Graves disease in children and adolescents"</a>.)</p><p>Sinus tachycardia commonly accompanies a visit to the doctor. This situational anxiety and the associated tachycardia typically resolve with reassurance.</p><p>Some patients with significant psychiatric distress due to anxiety, panic attack, or other mental illness may also present with palpitations. These patients warrant appropriate workup for potential organic causes, such as hyperthyroidism, and referral to a mental health specialist.</p><p class="headingAnchor" id="H747001137"><span class="h1">SOCIETY GUIDELINE LINKS</span><span class="headingEndMark"> — </span>Links to society and government-sponsored guidelines from selected countries and regions around the world are provided separately. (See  <a class="medical medical_society_guidelines" href="/z/d/html/116931.html" rel="external">"Society guideline links: Supraventricular arrhythmias"</a>.)</p><p class="headingAnchor" id="H16"><span class="h1">SUMMARY AND RECOMMENDATIONS</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Differential diagnosis</strong> – The table summarizes the causes of tachycardia, highlighting the most common and the most life threatening causes  (<a class="graphic graphic_table graphicRef71622" href="/z/d/graphic/71622.html" rel="external">table 1</a>). (See <a class="local">'Differential diagnosis'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Evaluation</strong> – Assessment for shock and the determination of rhythm are two key decision points in the evaluation of children with tachycardia. Children with sinus tachycardia and shock require immediate treatment while the underlying etiology is sought  (<a class="graphic graphic_algorithm graphicRef81356" href="/z/d/graphic/81356.html" rel="external">algorithm 3</a>). (See <a class="local">'Evaluation'</a> above.) </p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Algorithmic approach </strong>– The approach to the evaluation and initial management of tachycardia in children are summarized in the algorithms  (<a class="graphic graphic_algorithm graphicRef129940" href="/z/d/graphic/129940.html" rel="external">algorithm 1</a> and <a class="graphic graphic_algorithm graphicRef51655" href="/z/d/graphic/51655.html" rel="external">algorithm 2</a> and <a class="graphic graphic_algorithm graphicRef81356" href="/z/d/graphic/81356.html" rel="external">algorithm 3</a> and <a class="graphic graphic_algorithm graphicRef58268" href="/z/d/graphic/58268.html" rel="external">algorithm 4</a>). (See <a class="local">'Algorithmic approach'</a> above.)</p></div><div class="headingAnchor" id="references"><ol id="reference"><li><a class="nounderline abstract_t">Doniger SJ, Sharieff GQ. Pediatric dysrhythmias. Pediatr Clin North Am 2006; 53:85.</a></li><li class="breakAll">American Heart Association. CPR &amp; First Aid Emergency Cardiovascular Care (2020). https://cpr.heart.org/en/resuscitation-science/cpr-and-ecc-guidelines.</li><li><a class="nounderline abstract_t">Chandar JS, Wolff GS, Garson A Jr, et al. Ventricular arrhythmias in postoperative tetralogy of Fallot. Am J Cardiol 1990; 65:655.</a></li><li><a class="nounderline abstract_t">Moss AJ. Long QT Syndrome. JAMA 2003; 289:2041.</a></li><li><a class="nounderline abstract_t">Ackerman MJ. The long QT syndrome: ion channel diseases of the heart. Mayo Clin Proc 1998; 73:250.</a></li><li><a class="nounderline abstract_t">Garson A Jr, Bink-Boelkens M, Hesslein PS, et al. Atrial flutter in the young: a collaborative study of 380 cases. J Am Coll Cardiol 1985; 6:871.</a></li><li><a class="nounderline abstract_t">Maron BJ. Hypertrophic cardiomyopathy in childhood. Pediatr Clin North Am 2004; 51:1305.</a></li><li><a class="nounderline abstract_t">Bohn D, Benson L. Diagnosis and management of pediatric myocarditis. Paediatr Drugs 2002; 4:171.</a></li><li><a class="nounderline abstract_t">Liberman L, Hordof AJ, Alfayyadh M, et al. Torsade de pointes in a child with acute rheumatic fever. J Pediatr 2001; 138:280.</a></li><li><a class="nounderline abstract_t">Klein I, Ojamaa K. Thyroid hormone and the cardiovascular system: from theory to practice. J Clin Endocrinol Metab 1994; 78:1026.</a></li><li><a class="nounderline abstract_t">Channick BJ, Adlin EV, Marks AD, et al. Hyperthyroidism and mitral-valve prolapse. N Engl J Med 1981; 305:497.</a></li><li><a class="nounderline abstract_t">Daymont C, Bonafide CP, Brady PW. Heart rates in hospitalized children by age and body temperature. Pediatrics 2015; 135:e1173.</a></li><li><a class="nounderline abstract_t">Thompson M, Harnden A, Perera R, et al. Deriving temperature and age appropriate heart rate centiles for children with acute infections. Arch Dis Child 2009; 94:361.</a></li><li><a class="nounderline abstract_t">Davies P, Maconochie I. The relationship between body temperature, heart rate and respiratory rate in children. Emerg Med J 2009; 26:641.</a></li><li><a class="nounderline abstract_t">Wathen JE, Rewers AB, Yetman AT, Schaffer MS. Accuracy of ECG interpretation in the pediatric emergency department. Ann Emerg Med 2005; 46:507.</a></li><li><a class="nounderline abstract_t">Lennon D. Acute rheumatic fever in children: recognition and treatment. Paediatr Drugs 2004; 6:363.</a></li><li class="breakAll">Pediatric Advanced Life Support Provider Manual, American Heart Association, Dallas 2020. p.235.</li><li><a class="nounderline abstract_t">Ko JK, Deal BJ, Strasburger JF, Benson DW Jr. Supraventricular tachycardia mechanisms and their age distribution in pediatric patients. Am J Cardiol 1992; 69:1028.</a></li><li><a class="nounderline abstract_t">Delacrétaz E. Clinical practice. Supraventricular tachycardia. N Engl J Med 2006; 354:1039.</a></li><li><a class="nounderline abstract_t">Paul T, Pfammatter JP. Adenosine: an effective and safe antiarrhythmic drug in pediatrics. Pediatr Cardiol 1997; 18:118.</a></li><li><a class="nounderline abstract_t">Kaltman J, Shah M. Evaluation of the child with an arrhythmia. Pediatr Clin North Am 2004; 51:1537.</a></li></ol></div><div id="topicVersionRevision">Topic 6435 Version 23.0</div></div>
<div class="row">
<div class="col-12">
<h4 style="text-align: center;padding: 20px;color: cadetblue;">References</h4>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16487786" id="rid0" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>1 : Pediatric dysrhythmias.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16487786" id="rid1" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>2 : Pediatric dysrhythmias.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1689935" id="rid2" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>3 : Ventricular arrhythmias in postoperative tetralogy of Fallot.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12709446" id="rid3" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>4 : Long QT Syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9511785" id="rid4" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>5 : The long QT syndrome: ion channel diseases of the heart.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/4031302" id="rid5" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>6 : Atrial flutter in the young: a collaborative study of 380 cases.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15331286" id="rid6" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>7 : Hypertrophic cardiomyopathy in childhood.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11909009" id="rid7" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>8 : Diagnosis and management of pediatric myocarditis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11174632" id="rid8" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>9 : Torsade de pointes in a child with acute rheumatic fever.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8175954" id="rid9" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>10 : Thyroid hormone and the cardiovascular system: from theory to practice.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7254298" id="rid10" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>11 : Hyperthyroidism and mitral-valve prolapse.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25917984" id="rid11" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>12 : Heart rates in hospitalized children by age and body temperature.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19019883" id="rid12" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>13 : Deriving temperature and age appropriate heart rate centiles for children with acute infections.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19700579" id="rid13" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>14 : The relationship between body temperature, heart rate and respiratory rate in children.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16308065" id="rid14" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>15 : Accuracy of ECG interpretation in the pediatric emergency department.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15612837" id="rid15" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>16 : Acute rheumatic fever in children: recognition and treatment.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15612837" id="rid16" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>17 : Acute rheumatic fever in children: recognition and treatment.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1561973" id="rid17" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>18 : Supraventricular tachycardia mechanisms and their age distribution in pediatric patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16525141" id="rid18" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>19 : Clinical practice. Supraventricular tachycardia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9049125" id="rid19" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>20 : Adenosine: an effective and safe antiarrhythmic drug in pediatrics.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15561172" id="rid20" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>21 : Evaluation of the child with an arrhythmia.</p>
</a>
</div>
</div>
</div>
</div>
</section>
</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->
<!-- End Footer Area -->
<!-- Back to top -->
<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->
<!-- Prpper JS -->
<!-- Bootstrap Min JS -->
<!-- Classy Nav Min Js -->
<!-- Owl Carousel Min Js -->
<!-- Magnific Popup JS -->
<!-- CounterUp JS -->
<!-- Waypoints JS -->
<!-- Form Validator Min JS -->
<!-- Contact Form Min JS -->
<!-- Main JS -->
<!-- Global site tag (gtag.js) - Google Analytics -->
</body>
</html>
